Case Report
Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
Table 2
Pulmonary function tests from Case 2.
| | 2 June 2016 | 27 April 2017 | 26 April 2018 | 23 May 2019 | 1 November 2019 | 23 July 2020 |
| FVC | | | | | | | L | 2.32 | 2.36 | 2.40 | 2.21 | 2.11 | 1.80 | % predicted | 70 | 72 | 74 | 74 | 71 | 61 | FEV1 | | | | | | | L | 1.68 | 1.71 | 1.67 | 1.68 | 1.61 | 1.54 | % predicted | 67 | 69 | 68 | 72 | 69 | 67 | FEV1/FVC | 73 | 73 | 70 | 76 | 76 | 85 | DLCO | | | | | | | mL/mmHg/min | 14.93 | 17.13 | 14.57 | 13.76 | 14.86 | 11.50 | % predicted | 69 | 80 | 69 | 65 | 71 | 55 |
|
|
DLCO: diffusing capacity for carbon monoxide; FEV1: forced expiratory volume in one second; FVC: forced vital capacity.
|